Zachary J. Hauseman

Zachary J. Hauseman

Auto-generated profile, based on publicly available information

Zachary J. Hauseman

Department of Pediatric Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA; Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2022 in Nature
Verified
Journal Article
Open access
PDF file
ZHZachary J. Hauseman
Zachary J. Hauseman
MFMichelle Fodor
Michelle Fodor
ADAnxhela Dhembi
Anxhela Dhembi
JVJessica Viscomi
Jessica Viscomi
DEDavid Egli
David Egli
DKDaniel A. King
Daniel A. King
RAS–MAPK signalling is fundamental for cell proliferation and is altered in most human cancers1–3. However, our mechanistic understanding of how RAS signals through RAF is still incomplete. Although studies revealed snapshots for autoinhibited and active RAF–MEK1–14-3-3 complexes4, the intermediate steps that lead to RAF activation remain unclear. The MRAS–SHOC2–PP1C holophosphatase dephosphorylates RAF at serine 259, resulting in the partial displacement of 14-3-3 and RAF–RAS association3,5,6. MRAS, SHOC2 and PP1C are mutated in rasopathies—developmental syndromes caused by aberrant MAPK pathway activation6–14—and SHOC2 itself has emerged as potential target in receptor tyrosine kinase (RTK)–RAS-driven tumours15–18. Despite its importance, structural understanding of the SHOC2 holophosphatase is lacking. Here we determine, using X-ray crystallography, the structure of the MRAS–SHOC2–PP1C complex. SHOC2 bridges PP1C and MRAS through its concave surface and enables reciprocal interactions between all three subunits. Biophysical characterization indicates a cooperative assembly driven by the MRAS GTP-bound active state, an observation that is extendible to other RAS isoforms. Our findings support the concept of a RAS-driven and multi-molecular model for RAF activation in which individual RAS–GTP molecules recruit RAF–14-3-3 and SHOC2–PP1C to produce downstream pathway activation. Importantly, we find that rasopathy and cancer mutations reside at protein–protein interfaces within the holophosphatase, resulting in enhanced affinities and function. Collectively, our findings shed light on a fundamental mechanism of RAS biology and on mechanisms of clinically observed enhanced RAS–MAPK signalling, therefore providing the structural basis for therapeutic interventions.

12 June 2020 in Molecular Cell
Verified
Journal Article
Closed access
ZHZachary J. Hauseman
Zachary J. Hauseman
EHEdward P. Harvey
Edward P. Harvey
CNCatherine E. Newman
Catherine E. Newman
TWThomas E. Wales
Thomas E. Wales
JBJoel C. Bucci
Joel C. Bucci
LWLoren D. Walensky
Loren D. Walensky

1 June 2020 in Cell Chemical Biology
Verified
Journal Article
Closed access
EHEdward P. Harvey
Edward P. Harvey
ZHZachary J. Hauseman
Zachary J. Hauseman
DCDaniel T. Cohen
Daniel T. Cohen
TRT. Justin Rettenmaier
T. Justin Rettenmaier
SLSusan Lee
Susan Lee
LWLoren D. Walensky
Loren D. Walensky

1 January 2017 in Tetrahedron Letters
Verified
Journal Article
Closed access
KKKyle W. Knouse
Kyle W. Knouse
LALaura E. Ator
Laura E. Ator
LBLauren E. Beausoleil
Lauren E. Beausoleil
ZHZachary J. Hauseman
Zachary J. Hauseman
RCRebecca L. Casaubon
Rebecca L. Casaubon
GOGregory R. Ott
Gregory R. Ott

17 August 2020 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
ACAnn M. Cathcart
Ann M. Cathcart
GBGregory H. Bird
Gregory H. Bird
TWThomas E. Wales
Thomas E. Wales
HHHenry D. Herce
Henry D. Herce
EHEdward P. Harvey
Edward P. Harvey
LWLoren D. Walensky
Loren D. Walensky

30 April 2020 in Structure
Verified
Journal Article
Closed access
YBYael Ben-Nun
Yael Ben-Nun
HSHyuk-Soo Seo
Hyuk-Soo Seo
EHEdward P. Harvey
Edward P. Harvey
ZHZachary J. Hauseman
Zachary J. Hauseman
TWThomas E. Wales
Thomas E. Wales
LWLoren D. Walensky
Loren D. Walensky